In other countries
The same active substances on other registers, the same brand first.
- LutatheraEuropean Union · Advanced Accelerator ApplicationsSame brand
- LutatheraCroatiaSame brand
- LutatheraItaly · Soluzione per infusione · Novartis Europharm LimitedSame brand
- Lutathera 370 MBq/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · Novartis Europharm LimitedSame brand
- Lutathera Solution for Infusion 370 MBQ/MLSingapore · 370 Mbq/ml · injection, solution (radiopharmaceutical) · Novartis (Singapore) Pte LTDSame brand
- EndolucinBeta 40 GBq/mL, radiofarmaceutische precursor, oplossingNetherlands · Radiofarmaceutische uitgangsstof · ITM Medical Isotopes GmbHSame substance
- Ilumira 37 GBq/ml radiofarmaceutische uitgangsstof, oplossingNetherlands · Radiofarmaceutische uitgangsstof · Shine Europe B.V.Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Lutetium(177 lu)oxodotreotide
- Strength
- 370 MBq / ML
- Dosage form
- Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 10 Dec 2019
- Registration
- DIN 02484552
- Marketing authorisation holder
- Novartis Pharmaceuticals Canada INC
- ATC code
- V10XX04
- Group
- Various
- Supply
- SCHEDULE C